BreathSpec study
Start date:December 2018 End date:
April 2019 Co-ordinated by:
Julia Grahamslaw Main trial site:
Liverpool School of Tropical Medicine
A multicentre prospective, observational, longitudinal cohort study in adult patients with suspected upper or lower respiratory infection (URTI/LRTI) to identify a spectrum of biomarkers in exhaled breath to discriminate participants with bacterial RTI from participants without.
Identification of chemical biomarkers in exhaled breath that potentially discriminates participants with bacterial RTI from participants without.
Additional endpoints explored will be variations of the chemical spectrum from all participants using a portable GC-IMS device (Breathspec) stratified by confounding factors, such as (but not limited to) gender, age, antibiotic therapy and smoking status.
Local PI
Dr Matt Reed
Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine
Research Team
Fiona McCurrach
Senior Research Nurse
Julia Grahamslaw
Lead Research Nurse
Alison Williams
Senior Research Nurse
Clare Moceivei
Senior Research Nurse
Caroline Blackstock
AMU Senior Research Nurse
Sian Dalgleish
Senior Research Nurse
Dr Adam Lloyd
Honorary Research Fellow & Lecturer
Emma Nugent
Research Administrator
More EMERGE Trials
Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.
IONA
Identification of Novel Psychoactive Substances (IONA)
EMERGE Biobank
Developing a bioresource for all emergency presentations
EHA - Epidemiological analysis for the Hereditary Angioedema Disease is an international, multicentre, epidemiological study that aims to explore the feasibility of a new Dried Blood Spot (DBS) filtercard-based screening algorithm and thereby the prevalence of the Hereditary Angioedema.
EHA Study
EHA - Epidemiological analysis for the Hereditary Angioedema Disease